Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis.
about
Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment.Epsilon-aminocaproic acid prevents high glucose and insulin induced-invasiveness in MDA-MB-231 breast cancer cells, modulating the plasminogen activator system.
P2860
Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Activated thrombin-activatable ...... and extracellular proteolysis.
@ast
Activated thrombin-activatable ...... and extracellular proteolysis.
@en
type
label
Activated thrombin-activatable ...... and extracellular proteolysis.
@ast
Activated thrombin-activatable ...... and extracellular proteolysis.
@en
prefLabel
Activated thrombin-activatable ...... and extracellular proteolysis.
@ast
Activated thrombin-activatable ...... and extracellular proteolysis.
@en
P2093
P2860
P1433
P1476
Activated thrombin-activatable ...... and extracellular proteolysis
@en
P2093
Danielle Lanoue
Dora Cavallo-Medved
Janice Tubman
Lisa A Porter
Mouhanned El-Youssef
Rocco Romagnuolo
P2860
P2888
P356
10.1186/S12885-016-2359-1
P407
P577
2016-05-24T00:00:00Z
P6179
1052011231